SYSTEMIC LUPUS ERYTHEMATOSUS
Clinical trials for SYSTEMIC LUPUS ERYTHEMATOSUS explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC LUPUS ERYTHEMATOSUS trials appear
Sign up with your email to follow new studies for SYSTEMIC LUPUS ERYTHEMATOSUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lupus drug trial halted early: what happened with telitacicept?
Disease control TerminatedThis study tested whether the drug telitacicept could help control lupus symptoms better than a placebo. It included 91 people aged 12 to 70 with moderate-to-severe lupus. The trial was stopped early, so results are limited. The goal was to see if the drug could reduce disease ac…
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS
Phase: PHASE3 • Sponsor: Vor Biopharma • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
Lupus drug combo study halted early, but data may guide future care
Disease control TerminatedThis study tested two lupus treatments—mycophenolate mofetil alone or with voclosporin—in 12 adults with moderate-to-severe lupus. The goal was to see if matching treatment to a person's immune profile improves results. The trial was stopped early, but the data may help doctors c…
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
Lupus flare prevention drug trial halted early
Disease control TerminatedThis study tested a drug called PRV-3279 to see if it could prevent lupus flares in people with active systemic lupus erythematosus (SLE). Participants had moderate to severe disease and were first treated with steroids to calm their symptoms. The trial was stopped early and incl…
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS
Phase: PHASE2 • Sponsor: Provention Bio, a Sanofi Company • Aim: Disease control
Last updated Jun 02, 2026 11:39 UTC
-
COVID vaccine study in autoimmune patients halted early
Knowledge-focused TerminatedThis study aimed to measure the immune response to the COVID-19 vaccine in 78 adults with autoimmune or inflammatory diseases who take immunosuppressants or biologics. Researchers wanted to see if these medications reduce the vaccine's effectiveness. The study was terminated earl…
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:53 UTC